Biogen (BIIB) Misses Q1 EPS by 76c, Announces CEO Transition
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $196.58 -1.05%
EPS Growth %: -41.3%
Financial Fact:
Income from operations: 1.43B
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -41.3%
Financial Fact:
Income from operations: 1.43B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.62, $0.76 worse than the analyst estimate of $4.38. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.5 billion.
- Announces CEO Transition
- Reaffirms FY Guidance
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Rogers Jr. to leave Nike board after eight years of service
- ScottsMiracle-Gro names Nick Miaritis as chief brand officer
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
Corporate News, Earnings, Hot Corp. News, Hot Earnings, Hot Mgmt Changes, Management ChangesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
